Explore ViiV Healthcare
Our medicines
| Product brand name (generic name) |
Class |
|---|---|
| 3TC® (lamivudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Celsentri® (maraviroc) | CCR5 antagonist |
| Combivir® (lamivudine/zidovudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Dovato (dolutegravir/lamivudine) | Integrase inhibitor (INI) and Non-nucleoside reverse transcriptase inhibitor (NNRTI) |
| Juluca® (dolutegravir/rilpivirine) | Integrase inhibitor (INI) and Non-nucleoside reverse transcriptase inhibitor (NNRTI) |
| Kivexa® (abacavir/lamivudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Retrovir® (zidovudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Telzir® (fosamprenavir) | Protease inhibitor (PI) |
| Tivicay® (dolutegravir) | Integrase inhibitor (INI) |
| Triumeq® (dolutegravir/abacavir/lamivudine) | Integrase inhibitor (INI) and Nucleoside reverse transcriptase inhibitor (NRTI) |
| Trizivir® (abacavir/lamivudine/zidovudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Ziagen® (abacavir) | Nucleoside reverse transcriptase inhibitor (NRTI) |
Date of preparation: June 2018 | AUS/HIV/0077/18